Multipel Sclerosis

Press Releases

AHN Specialists Studying New Treatment for Relapsing Multiple Sclerosis

PITTSBURGH, PA – Doctors at Allegheny Health Network (AHN), led by neurologist Troy Desai, MD, are exploring the use of a new drug to treat relapsing or primary progressive multiple sclerosis (MS). AHN is one of 276+ worldwide participating in the FENhance study, a Phase III clinical trial to assess the safety and efficacy of the drug Fenebrutinib compared to an approved…